Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

@article{Marzano2001PreventionOH,
  title={Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.},
  author={A. Marzano and M. Salizzoni and W. Debernardi-Venon and A. Smedile and A. Franchello and A. Ciancio and E. Gentilcore and P. Piantino and A. Barbui and E. David and F. Negro and M. Rizzetto},
  journal={Journal of hepatology},
  year={2001},
  volume={34 6},
  pages={
          903-10
        }
}
BACKGROUND/AIMS Treatment with hepatitis B virus immune globulins (HBIG) or lamivudine has reduced the rate of hepatitis B recurrence after liver transplantation to approximately 50%. METHODS To further decrease hepatitis B recurrence, 33 hepatitis B virus (HBV)-related cirrhotic patients were treated with lamivudine before liver transplantation and with lamivudine together with low-dose HBIG (46 500 IU the first month followed by 5,000 lU/monthly) after surgery. RESULTS While on lamivudine… Expand
Combined Lamivudine and Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Recurrence after Liver Transplantation: Long‐Term Results
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine‐resistant mutants
  • A. Marzano, P. Lampertico, +8 authors M. Rizzetto
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2005
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis
  • Shusen Zheng, Yaomin Chen, +4 authors Min Zhang
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2006
High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence †
  • J. Chun, W. Kim, +7 authors H. Lee
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2010
Hepatitis B: Progress in the last 15 years
  • F. Villamil
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2002
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
  • F. Yao, R. Osorio, +4 authors R. Gish
  • Medicine
  • Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 1999
Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.
  • E. Yoshida, S. Erb, +5 authors U. Steinbrecher
  • Medicine
  • Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 1999
Liver transplantation in European patients with the hepatitis B surface antigen.
...
1
2
3
...